Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications

Journal of Hepatology

Volumn 61, Issue 2, 2014, Pages 408-417

  Pollicino, Teresa ^a   Cacciola, Irene ^a   Saffioti, Francesca ^a   Raimondo, Giovanni ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Endoplasmic reticulum stress signaling pathway; Ground glass hepatocytes; HBV preS S genetic variability; Hepatocellular carcinoma; Occult HBV infection; Vaccine escape variants

Indexed keywords

DNA; ENVELOPE PROTEIN; HEPATITIS B ANTIBODY; HEPATITIS VACCINE; MEMBRANE PROTEIN; HEPATITIS B SURFACE ANTIGEN; PRESURFACE PROTEIN 1, HEPATITIS B SURFACE ANTIGEN; PRESURFACE PROTEIN 2, HEPATITIS B SURFACE ANTIGEN; PROTEIN PRECURSOR;

CHOLESTATIC HEPATITIS; DNA DAMAGE; ENDOPLASMIC RETICULUM; GENETIC ORGANIZATION; GENETIC VARIABILITY; GENOMICS; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER CIRRHOSIS; NONHUMAN; PATHOGENICITY; PRES S GENE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; VIRUS REPLICATION; COMPLICATION; GENETICS; MUTATION; VIROLOGY;

HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; MUTATION; PROTEIN PRECURSORS;

EID: 84904739213     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.04.041     Document Type: Review

References (155)

1. J.L. Dienstag Hepatitis B virus infection N Engl J Med 359 2008 1486 1500
2. F.V. Chisari, and C. Ferrari Hepatitis B virus immunopathogenesis Annu Rev Immunol 13 1995 29 60
3. S. Locarnini, and F. Zoulim Molecular genetics of HBV infection Antivir Ther 15 2010 3 14
4. T. Pollicino, S. Campo, and G. Raimondo PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection Virology 208 1995 672 677
5. Y.F. Fan, C.C. Lu, W.C. Chen, W.J. Yao, H.C. Wang, and T.T. Chang et al. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection Hepatology 33 2001 277 286
6. B.F. Chen, C.J. Liu, G.M. Jow, P.J. Chen, J.H. Kao, and D.S. Chen High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases Gastroenterology 130 2006 1153 1168
7. C.H. Chen, C.H. Hung, C.M. Lee, T.H. Hu, J.H. Wang, and J.C. Wang et al. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients Gastroenterology 133 2007 1466 1474
8. M.S. Choi, D.Y. Kim, D.H. Lee, J.H. Lee, K.C. Koh, and S.W. Paik et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection J Viral Hepat 14 2007 161 168
9. G. Raimondo, L. Costantino, G. Caccamo, T. Pollicino, G. Squadrito, and I. Cacciola et al. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases J Hepatol 40 2004 515 519
10. T. Pollicino, A.R. Zanetti, I. Cacciola, M.A. Petit, A. Smedile, and S. Campo et al. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis Hepatology 26 1997 495 499
11. H.Y. Hsu, M.H. Chang, Y.H. Ni, H.H. Lin, S.M. Wang, and D.S. Chen Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis Hepatology 26 1997 786 791
12. W.F. Carman, A.R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, and E. Tanzi et al. Vaccine-induced escape mutant of hepatitis B virus Lancet 336 1990 325 329
13. M.W. Lai, T.Y. Lin, K.C. Tsao, C.G. Huang, M.J. Hsiao, and K.H. Liang et al. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination Gastroenterology 143 2012 400 407
14. H.C. Wang, W. Huang, M.D. Lai, and I.J. Su Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis Cancer Sci 97 2006 683 688
15. U. Protzer-Knolle, U. Naumann, R. Bartenschlager, T. Berg, U. Hopf, and K.H. Meyer zum Buschenfelde et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation Hepatology 27 1998 254 263
16. M.G. Ghany, B. Ayola, F.G. Villamil, R.G. Gish, S. Rojter, and J.M. Vierling et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis Hepatology 27 1998 213 222
17. C. Seeger, and W.S. Mason Hepatitis B virus biology Microbiol Mol Biol Rev 64 2000 51 68
18. H. Norder, A.M. Courouce, and L.O. Magnius Molecular basis of hepatitis B virus serotype variations within the four major subtypes J Gen Virol 73 1992 3141 3145
19. M. Nassal Hepatitis B viruses: reverse transcription a different way Virus Res 134 2008 235 249
20. M. Levrero, T. Pollicino, J. Petersen, L. Belloni, G. Raimondo, and M. Dandri Control of cccDNA function in hepatitis B virus infection J Hepatol 51 2009 581 592
21. R. Bonilla Guerrero, and L.R. Roberts The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma J Hepatol 42 2005 760 777
22. Y.Y. Zhang, B.H. Zhang, D. Theele, S. Litwin, E. Toll, and J. Summers Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver Proc Natl Acad Sci U S A 100 2003 12372 12377
23. V. Bruss Hepatitis B virus morphogenesis World J Gastroenterol 13 2007 65 73
24. K. Madalinski, B. Burczynska, K.H. Heermann, A. Uy, and W.H. Gerlich Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus Clin Exp Immunol 84 1991 493 500
25. P. Vanlandschoot, and G. Leroux-Roels Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus? Trends Immunol 24 2003 144 147
26. K.H. Heermann, U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W.H. Gerlich Large surface proteins of hepatitis B virus containing the pre-s sequence J Virol 52 1984 396 402
27. S. Locarnini, and S. Bowden Hepatitis B surface antigen quantification: not what it seems on the surface Hepatology 56 2012 411 414
28. S. Schadler, and E. Hildt HBV life cycle: entry and morphogenesis Viruses 1 2009 185 209
29. S. Locarnini, J. McMillan, and A. Bartholomeusz The hepatitis B virus and common mutants Semin Liver Dis 23 2003 5 20
30. D. Zhang, P. Dong, K. Zhang, L. Deng, C. Bach, and W. Chen et al. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment BMC Microbiol 12 2012 307
31. T. Santantonio, M.C. Jung, R. Schneider, D. Fernholz, M. Milella, and L. Monno et al. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy Virology 188 1992 948 952
32. S. Liu, H. Zhang, C. Gu, J. Yin, Y. He, and J. Xie et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis J Natl Cancer Inst 101 2009 1066 1082
33. V. Bruss, and D. Ganem The role of envelope proteins in hepatitis B virus assembly Proc Natl Acad Sci U S A 88 1991 1059 1063
34. D. Fernholz, P.R. Galle, M. Stemler, M. Brunetto, F. Bonino, and H. Will Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier Virology 194 1993 137 148
35. L.J. Stuyver, S.A. Locarnini, A. Lok, D.D. Richman, W.F. Carman, and J.L. Dienstag et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region Hepatology 33 2001 751 757
36. J. Torresi The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus J Clin Virol 25 2002 97 106
37. T.T. Wu, L. Coates, C.E. Aldrich, J. Summers, and W.S. Mason In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway Virology 175 1990 255 261
38. F. Zoulim New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA J Hepatol 42 2005 302 308
39. F. Zoulim Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection Antiviral Res 64 2004 1 15
40. T. Pollicino, G. Amaddeo, A. Restuccia, G. Raffa, A. Alibrandi, and G. Cutroneo et al. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels Hepatology 56 2012 434 443
41. F.V. Chisari, P. Filippi, A. McLachlan, D.R. Milich, M. Riggs, and S. Lee et al. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice J Virol 60 1986 880 887
42. F.V. Chisari, P. Filippi, J. Buras, A. McLachlan, H. Popper, and C.A. Pinkert et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice Proc Natl Acad Sci U S A 84 1987 6909 6913
43. D.H. Persing, H.E. Varmus, and D. Ganem Inhibition of secretion of hepatitis B surface antigen by a related presurface polypeptide Science 234 1986 1388 1391
44. C.T. Bock, H.L. Tillmann, M.P. Manns, and C. Trautwein The pre-S region determines the intracellular localization and appearance of hepatitis B virus Hepatology 30 1999 517 525
45. J. Summers, P.M. Smith, M.J. Huang, and M.S. Yu Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus J Virol 65 1991 1310 1317
46. H. Guo, D. Jiang, T. Zhou, A. Cuconati, T.M. Block, and J.T. Guo Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation J Virol 81 2007 12472 12484
47. W. Gao, and J. Hu Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein J Virol 81 2007 6164 6174
48. J. Summers, P.M. Smith, and A.L. Horwich Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification J Virol 64 1990 2819 2824
49. T.B. Lentz, and D.D. Loeb Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus J Virol 85 2011 11916 11927
50. J. Kock, C. Rosler, J.J. Zhang, H.E. Blum, M. Nassal, and C. Thoma Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner PLoS Pathog 6 2010 e1001082
51. R.J. Lenhoff, and J. Summers Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes J Virol 68 1994 5706 5713
52. R.J. Lenhoff, C.A. Luscombe, and J. Summers Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus Hepatology 29 1999 563 571
53. J. Torresi Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin Antivir Ther 13 2008 337 340
54. Y.H. Ni, M.H. Chang, J.F. Wu, H.Y. Hsu, H.L. Chen, and D.S. Chen Minimization of hepatitis B infection by a 25-year universal vaccination program J Hepatol 57 2012 730 735
55. W.H. Gerlich Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation J Clin Virol 36 2006 S18 S22
56. F.B. Hollinger Hepatitis B virus genetic diversity and its impact on diagnostic assays J Viral Hepat 14 2007 11 15
57. W.H. Gerlich, D. Glebe, and C.G. Schuttler Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus J Viral Hepat 14 2007 16 21
58. H.L. Chiou, T.S. Lee, J. Kuo, Y.C. Mau, and M.S. Ho Altered antigenicity of 'a' determinant variants of hepatitis B virus J Gen Virol 78 1997 2639 2645
59. G. Francois, M. Kew, P. Van Damme, M.J. Mphahlele, and A. Meheus Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine 19 2001 3799 3815
60. C.J. Clements, B. Coghlan, M. Creati, S. Locarnini, R.S. Tedder, and J. Torresi Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization? Bull World Health Organ 88 2010 66 73
61. B. Weber Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact J Clin Virol 32 2005 102 112
62. J.M. Pawlotsky The concept of hepatitis B virus mutant escape J Clin Virol 34 2005 S125 S129
63. K. Yamamoto, M. Horikita, F. Tsuda, K. Itoh, Y. Akahane, and S. Yotsumoto et al. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen J Virol 68 1994 2671 2676
64. J. Hou, P. Karayiannis, J. Waters, K. Luo, C. Liang, and H.C. Thomas A unique insertion in the S gene of surface antigen-negative hepatitis B virus Chinese carriers Hepatology 21 1995 273 278
65. J. Kato, K. Hasegawa, N. Torii, K. Yamauchi, and N. Hayashi A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B Hepatology 23 1996 389 395
66. G. McMahon, P.H. Ehrlich, Z.A. Moustafa, L.A. McCarthy, D. Dottavio, and M.D. Tolpin et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients Hepatology 15 1992 757 766
67. W.F. Carman, C. Trautwein, F.J. van Deursen, K. Colman, E. Dornan, and G. McIntyre et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis Hepatology 24 1996 489 493
68. A.E. Hawkins, R.J. Gilson, N. Gilbert, T.G. Wreghitt, J.J. Gray, and I. Ahlers-de Boer et al. Hepatitis B virus surface mutations associated with infection after liver transplantation J Hepatol 24 1996 8 14
69. C.T. Yeh Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy Antivir Ther 15 2010 471 475
70. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 2009 e1 e2
71. J. Sheldon, and V. Soriano Hepatitis B virus escape mutants induced by antiviral therapy J Antimicrob Chemother 61 2008 766 768
72. M.H. Chang Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants Antivir Ther 15 2010 463 469
73. C.W. Hsu, C.T. Yeh, M.L. Chang, and Y.F. Liaw Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance Gastroenterology 132 2007 543 550
74. C.J. Liu, J.H. Kao, W.Y. Shau, P.J. Chen, M.Y. Lai, and D.S. Chen Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease J Med Virol 68 2002 50 59
75. T. Pollicino, G. Isgro, R. Di Stefano, D. Ferraro, S. Maimone, and S. Brancatelli et al. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients Antivir Ther 14 2009 649 654
76. J. Hou, Z. Wang, J. Cheng, Y. Lin, G.K. Lau, and J. Sun et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers Hepatology 34 2001 1027 1034
77. C. De Maddalena, C. Giambelli, E. Tanzi, D. Colzani, M. Schiavini, and L. Milazzo et al. High level of genetic heterogeneity in S and P genes of genotype D hepatitis B virus Virology 365 2007 113 124
78. N. Ogata, A.R. Zanetti, M. Yu, R.H. Miller, and R.H. Purcell Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant J Infect Dis 175 1997 511 523
79. B.C. Song, S.H. Kim, H. Kim, Y.H. Ying, H.J. Kim, and Y.J. Kim et al. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically J Med Virol 76 2005 194 202
80. T.J. Harrison, and A.J. Zuckerman Variants of hepatitis B virus Vox Sang 63 1992 161 167
81. S.A. Locarnini Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance Hepatology 27 1998 294 297
82. C.M. Hunt, J.M. McGill, M.I. Allen, and L.D. Condreay Clinical relevance of hepatitis B viral mutations Hepatology 31 2000 1037 1044
83. E. Kajiwara, Y. Tanaka, T. Ohashi, K. Uchimura, S. Sadoshima, and M. Kinjo et al. Hepatitis B caused by a hepatitis B surface antigen escape mutant J Gastroenterol 43 2008 243 247
84. V. Thakur, S.N. Kazim, R.C. Guptan, S.E. Hasnain, A. Bartholomeusz, and V. Malhotra et al. Transmission of G145R mutant of HBV to an unrelated contact J Med Virol 76 2005 40 46
85. H.Y. Hsu, M.H. Chang, Y.H. Ni, C.L. Chiang, H.L. Chen, and J.F. Wu et al. No increase in prevalence of hepatitis B surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization J Infect Dis 201 2010 1192 1200
86. G. Raimondo, G. Caccamo, R. Filomia, and T. Pollicino Occult HBV infection Semin Immunopathol 35 2013 39 52
87. S. Biswas, D. Candotti, and J.P. Allain Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection J Virol 87 2013 7882 7892
88. B. Roche, A.M. Roque-Afonso, M. Sebagh, V. Delvart, J.C. Duclos-Vallee, and D. Castaing et al. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins Liver Transpl 16 2010 885 894
89. G. Raimondo, T. Pollicino, I. Cacciola, and G. Squadrito Occult hepatitis B virus infection J Hepatol 46 2007 160 170
90. C.H. Huang, Q. Yuan, P.J. Chen, Y.L. Zhang, C.R. Chen, and Q.B. Zheng et al. Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors J Hepatol 57 2012 720 729
91. F.B. Hollinger Hepatitis B virus infection and transfusion medicine: science and the occult Transfusion 48 2008 1001 1026
92. D. Candotti, and J.P. Allain Transfusion-transmitted hepatitis B virus infection J Hepatol 51 2009 798 809
93. S.L. Stramer, U. Wend, D. Candotti, G.A. Foster, F.B. Hollinger, and R.Y. Dodd et al. Nucleic acid testing to detect HBV infection in blood donors N Engl J Med 364 2011 236 247
94. F.B. Hollinger, and G. Sood Occult hepatitis B virus infection: a covert operation J Viral Hepat 17 2010 1 15
95. J.P. Allain, and L. Cox Challenges in hepatitis B detection among blood donors Curr Opin Hematol 18 2011 461 466
96. W.J. Su, M.C. Ho, Y.H. Ni, J.F. Wu, Y.M. Jeng, and H.L. Chen et al. Clinical course of de novo hepatitis B infection after pediatric liver transplantation Liver Transpl 16 2010 215 221
97. S. Shahmoradi, Y. Yahyapour, M. Mahmoodi, S.M. Alavian, Z. Fazeli, and S.M. Jazayeri High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG J Hepatol 57 2012 515 521
98. C.T. Yeh, and M.W. Lai Eliminating hepatitis B virus through neonatal vaccination: can we make it? J Hepatol 57 2012 484 485
99. G. Gerken, D. Kremsdorf, M.A. Petit, M. Manns, K.H. Meyer zum Buschenfelde, and C. Brechot Hepatitis B defective virus with rearrangements in the preS gene during HBV chronic infection J Hepatol 13 1991 S93 S96
100. M. Melegari, S. Bruno, and J.R. Wands Properties of hepatitis B virus pre-S1 deletion mutants Virology 199 1994 292 300
101. P.C. Tai, F.M. Suk, W.H. Gerlich, A.R. Neurath, and C. Shih Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants Virology 292 2002 44 58
102. M. Sterneck, S. Gunther, J. Gerlach, N.V. Naoumov, T. Santantonio, and L. Fischer et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis J Hepatol 26 1997 754 764
103. T. Kalinina, A. Riu, L. Fischer, H. Will, and M. Sterneck A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis Hepatology 34 2001 385 394
104. K. Ando, T. Moriyama, L.G. Guidotti, S. Wirth, R.D. Schreiber, and H.J. Schlicht et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis J Exp Med 178 1993 1541 1554
105. C. Trautwein, H. Schrem, H.L. Tillmann, S. Kubicka, D. Walker, and K.H. Boker et al. Hepatitis B virus mutations in the pre-S genome before and after liver transplantation Hepatology 24 1996 482 488
106. C.T. Bock, H.L. Tillmann, H.J. Maschek, M.P. Manns, and C. Trautwein A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and misassembly Gastroenterology 113 1997 1976 1982
107. S.A. Zanati, S.A. Locarnini, J.P. Dowling, P.W. Angus, F.J. Dudley, and S.K. Roberts Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine J Clin Virol 31 2004 53 57
108. S.N. Thung Histologic findings in recurrent HBV Liver Transpl 12 2006 S50 S53
109. S.Y. Xiao, L. Lu, and H.L. Wang Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis Int J Clin Exp Pathol 1 2008 396 402
110. J.Y. Lau, V.G. Bain, S.E. Davies, J.G. O'Grady, A. Alberti, and G.J. Alexander et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis Gastroenterology 102 1992 956 962
111. A.L. Mason, M. Wick, H.M. White, K.G. Benner, R.G. Lee, and F. Regenstein et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis Gastroenterology 105 1993 237 244
112. N.C. Foo, B.Y. Ahn, X. Ma, W. Hyun, and T.S. Yen Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein Hepatology 36 2002 1400 1407
113. V. Bruss Revisiting the cytopathic effect of hepatitis B virus infection Hepatology 36 2002 1327 1329
114. F. Sugauchi, T. Ohno, E. Orito, H. Sakugawa, T. Ichida, and M. Komatsu et al. Influence of hepatitis B virus genotypes on the development of preS deletions and advanced liver disease J Med Virol 70 2003 537 544
115. F.V. Chisari, K. Klopchin, T. Moriyama, C. Pasquinelli, H.A. Dunsford, and S. Sell et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice Cell 59 1989 1145 1156
116. T.M. Hagen, S. Huang, J. Curnutte, P. Fowler, V. Martinez, and C.M. Wehr et al. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma Proc Natl Acad Sci U S A 91 1994 12808 12812
117. S.N. Huang, and F.V. Chisari Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice Hepatology 21 1995 620 626
118. E. Hildt, and P.H. Hofschneider The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways Recent Results Cancer Res 154 1998 315 329
119. E. Hildt, B. Munz, G. Saher, K. Reifenberg, and P.H. Hofschneider The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice EMBO J 21 2002 525 535
120. F. Luan, H. Liu, L. Gao, J. Liu, Z. Sun, and Y. Ju et al. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT Gut 58 2009 1528 1537
121. V. Schluter, M. Meyer, P.H. Hofschneider, R. Koshy, and W.H. Caselmann Integrated hepatitis B virus X and 3′ truncated preS/S sequences derived from human hepatomas encode functionally active transactivators Oncogene 9 1994 3335 3344
122. S. Zhong, J.Y. Chan, W. Yeo, J.S. Tam, and P.J. Johnson Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues J Viral Hepat 6 1999 195 202
123. Y.H. Hsieh, I.J. Su, H.C. Wang, W.W. Chang, H.Y. Lei, and M.D. Lai et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage Carcinogenesis 25 2004 2023 2032
124. H.C. Wang, W.T. Chang, W.W. Chang, H.C. Wu, W. Huang, and H.Y. Lei et al. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes Hepatology 41 2005 761 770
125. P. Yeung, D.K. Wong, C.L. Lai, J. Fung, W.K. Seto, and M.F. Yuen Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B J Infect Dis 203 2011 646 654
126. L.H. Wang, W. Huang, M.D. Lai, and I.J. Su Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis Carcinogenesis 33 2012 466 472
127. H.P. Huang, H.Y. Hsu, C.L. Chen, Y.H. Ni, H.Y. Wang, and D.J. Tsuei et al. Pre-S2 deletions of hepatitis B virus and hepatocellular carcinoma in children Pediatr Res 67 2010 90 94
128. C.H. Chen, C.S. Changchien, C.M. Lee, C.H. Hung, T.H. Hu, and J.H. Wang et al. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study J Infect Dis 198 2008 1634 1642
129. T. Pollicino, C. Saitta, and G. Raimondo Hepatocellular carcinoma: the point of view of the hepatitis B virus Carcinogenesis 32 2011 1122 1132
130. A. Kay, and F. Zoulim Hepatitis B virus genetic variability and evolution Virus Res 127 2007 164 176
131. H.C. Wang, H.C. Wu, C.F. Chen, N. Fausto, H.Y. Lei, and I.J. Su Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress Am J Pathol 163 2003 2441 2449
132. I.J. Su, H.C. Wang, H.C. Wu, and W.Y. Huang Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection J Gastroenterol Hepatol 23 2008 1169 1174
133. H.W. Tsai, Y.J. Lin, P.W. Lin, H.C. Wu, K.H. Hsu, and C.J. Yen et al. A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery Cancer 117 2011 2951 2960
134. A.M. Mathai, J. Alexander, F.Y. Kuo, M. Torbenson, P.E. Swanson, and M.M. Yeh Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B Hum Pathol 44 2013 1665 1671
135. J.H. Hung, I.J. Su, H.Y. Lei, H.C. Wang, W.C. Lin, and W.T. Chang et al. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase J Biol Chem 279 2004 46384 46392
136. Y.H. Hsieh, I.J. Su, H.C. Wang, J.H. Tsai, Y.J. Huang, and W.W. Chang et al. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1 Mol Cancer Res 5 2007 1063 1072
137. J.C. Yang, C.F. Teng, H.C. Wu, H.W. Tsai, H.C. Chuang, and T.F. Tsai et al. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis Hepatology 49 2009 1962 1971
138. M.W. Lai, and C.T. Yeh The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant Antivir Ther 13 2008 875 879
139. S. Hadziyannis, M.A. Gerber, C. Vissoulis, and H. Popper Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers Arch Pathol 96 1973 327 330
140. W.H. Caselmann, M. Meyer, A.S. Kekule, U. Lauer, P.H. Hofschneider, and R. Koshy A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA Proc Natl Acad Sci U S A 87 1990 2970 2974
141. A.S. Kekule, U. Lauer, M. Meyer, W.H. Caselmann, P.H. Hofschneider, and R. Koshy The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator Nature 343 1990 457 461
142. E. Hildt, G. Saher, V. Bruss, and P.H. Hofschneider The hepatitis B virus large surface protein (LHBs) is a transcriptional activator Virology 225 1996 235 239
143. J. Lupberger, and E. Hildt Hepatitis B virus-induced oncogenesis World J Gastroenterol 13 2007 74 81
144. X. Liang, J. Du, Y. Liu, M. Cui, C. Ma, and L. Han et al. The hepatitis B virus protein MHBs(t) sensitizes hepatoma cells to TRAIL-induced apoptosis through ERK2 Apoptosis 12 2007 1827 1836
145. E. Hildt, S. Urban, and P.H. Hofschneider Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator Oncogene 11 1995 2055 2066
146. S.A. Lee, K. Kim, H. Kim, and B.J. Kim Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases J Hepatol 56 2012 63 69
147. N. Warner, and S. Locarnini The antiviral drug selected hepatitis B virus rtA181T/sW172 - mutant has a dominant negative secretion defect and alters the typical profile of viral rebound Hepatology 48 2008 88 98
148. M.W. Lai, S.F. Huang, C.W. Hsu, M.H. Chang, Y.F. Liaw, and C.T. Yeh Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy Antivir Ther 14 2009 249 261
149. G.V. Papatheodoridis, P. Lampertico, S. Manolakopoulos, and A. Lok Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review J Hepatol 53 2010 348 356
150. G.V. Papatheodoridis, S. Manolakopoulos, G. Touloumi, G. Vourli, M. Raptopoulou-Gigi, and I. Vafiadis-Zoumbouli et al. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET Greece cohort study Gut 60 2011 1109 1116
151. K. Ohkawa, T. Takehara, M. Kato, M. Deguchi, M. Kagita, and H. Hikita et al. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus J Infect Dis 198 2008 1150 1158
152. V. Di Marco, A. Marzano, P. Lampertico, P. Andreone, T. Santantonio, and P.L. Almasio et al. Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine Hepatology 40 2004 883 891
153. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, and H. Yuen et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
154. S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote, T.T. Chang, G. Kitis, and M. Rizzetto et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 2006 1743 1751
155. P. Lampertico, M. Vigano, E. Manenti, M. Iavarone, E. Sablon, and M. Colombo Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients Gastroenterology 133 2007 1445 1451